NasdaqGM - Nasdaq Real Time Price USD

Kodiak Sciences Inc. (KOD)

4.1300
+0.3600
+(9.55%)
At close: May 12 at 4:00:01 PM EDT
3.9800
-0.15
(-3.63%)
After hours: May 12 at 6:13:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
186,849
186,849
277,321
341,379
267,051
Operating Income
-186,849
-186,849
-277,321
-341,379
-267,051
Net Non Operating Interest Income Expense
11,148
11,148
16,720
7,053
251
Other Income Expense
-506
-506
110
503
-190
Pretax Income
-176,207
-176,207
-260,491
-333,823
-266,990
Net Income Common Stockholders
-176,207
-176,207
-260,491
-333,823
-266,990
Diluted NI Available to Com Stockholders
-176,207
-176,207
-260,491
-333,823
-266,990
Basic EPS
-3.35
--
-4.97
-6.39
-5.16
Diluted EPS
-3.35
--
-4.97
-6.39
-5.16
Basic Average Shares
52,583.1480
--
52,414.2560
52,249.6200
51,788.9180
Diluted Average Shares
52,583.1480
--
52,414.2560
52,249.6200
51,788.9180
Total Operating Income as Reported
-186,849
-186,849
-277,321
-341,379
-267,051
Total Expenses
186,849
186,849
277,321
341,379
267,051
Net Income from Continuing & Discontinued Operation
-176,207
-176,207
-260,491
-333,823
-266,990
Normalized Income
-176,207
-176,207
-260,491
-333,823
-266,990
Interest Income
11,148
11,148
16,733
7,071
298
Interest Expense
0
0
13
18
47
Net Interest Income
11,148
11,148
16,720
7,053
251
EBIT
-176,207
-176,207
-260,478
-333,805
-266,943
EBITDA
-149,501
-149,501
-234,531
-322,804
-258,232
Reconciled Depreciation
26,706
26,706
25,947
11,001
8,711
Net Income from Continuing Operation Net Minority Interest
-176,207
-176,207
-260,491
-333,823
-266,990
Normalized EBITDA
-149,501
-149,501
-234,531
-322,804
-258,232
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/4/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

REPL Replimune Group, Inc.
7.86
+1.95%
 
DSGN Design Therapeutics, Inc.
3.6200
+3.43%
 
RLAY Relay Therapeutics, Inc.
3.1100
+3.67%
 
ACAD ACADIA Pharmaceuticals Inc.
17.52
+0.46%
 
PRLD Prelude Therapeutics Incorporated
0.8827
+13.02%
 
EWTX Edgewise Therapeutics, Inc.
14.82
+1.65%
 
RGNX REGENXBIO Inc.
7.97
+5.98%
 
ZNTL Zentalis Pharmaceuticals, Inc.
1.2900
+4.88%
 
VIR Vir Biotechnology, Inc.
5.30
+4.23%
 
VOR Vor Biopharma Inc.
0.1725
+14.01%